Silver Oak Securities’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$460K Sell
3,641
-173
-5% -$22.8K 0.03% 491
2026
Q1
$532K Buy
3,814
+50
+1% +$7K 0.04% 416
2025
Q4
$464K Sell
3,764
-20
-0.5% -$2.43K 0.03% 482
2025
Q3
$420K Buy
3,784
+44
+1% +$5K 0.03% 475
2025
Q2
$415K Buy
+3,740
New +$398K 0.03% 458
2023
Q2
Sell
-4,655
Closed -$386K 454
2023
Q1
$386K Sell
4,655
-208
-4% -$17.2K 0.06% 242
2022
Q4
$417K Buy
+4,863
New +$385K 0.08% 182
2022
Q3
Sell
-6,928
Closed -$421K 469
2022
Q2
$421K Buy
6,928
+293
+4% +$18.1K 0.09% 146
2022
Q1
$413K Buy
+6,635
New +$424K 0.08% 182

Other funds holding GILD

Silver Oak Securities's GILD Position: Q2 2026 in Review

Silver Oak Securities reduced its Gilead Sciences (GILD) stake by 4.5% in Q2 2026, selling an estimated $22.8K and leaving 3,641 shares worth $460K. The position accounts for 0.03% of the portfolio, ranked #491.

Silver Oak Securities first reported a position in GILD in Q1 2022 and has held it in 9 quarters since. The position peaked at $532K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Silver Oak Securities held 3,641 shares of Gilead Sciences worth $460K as of Q2 2026.
  • Silver Oak Securities sold 173 Gilead Sciences shares in Q2 2026, an estimated $22.8K.
  • Gilead Sciences made up 0.03% of Silver Oak Securities's portfolio in Q2 2026, its #491 holding.
  • Silver Oak Securities first reported a position in Gilead Sciences in Q1 2022 and has held it in 9 quarters since.
  • Silver Oak Securities's Gilead Sciences position peaked at $532K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Silver Oak Securities's 13F filing for Q2 2026, filed 7 Aug 2026.